Open access · CC-BY
via OpenAlex
The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome
Nielson T. Baxter, Nicholas A. Lesniak, Hamide Sinani, Patrick D. Schloss, Nicole M. Koropatkin
mSphere · 2019 · ▲ 99 citations
Abstract
The gut microbial community has a profound influence on host physiology in both health and disease. In diabetic individuals, the gut microbiota can affect the course of disease, and some medications for diabetes, including metformin, seem to elicit some of their benefits via an interaction with the microbiota. Here, we report that acarbose, a glucoamylase inhibitor for type 2 diabetes, changes the murine gut bacterial community structure in a reversible and diet-dependent manner. In both high-starch and high-fiber diet backgrounds, acarbose treatment results in increased short-chain fatty acids, particularly butyrate, as measured in stool samples. As we learn more about how human disease is affected by the intestinal bacterial community, the interplay between medications such as acarbose and the diet will become increasingly important to evaluate.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1128/msphere.00528-18
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Baxter, N.T., Lesniak, N.A., Sinani, H., Schloss, P.D., & Koropatkin, N.M. (2019). The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome. <em>mSphere</em>. https://doi.org/10.1128/msphere.00528-18
Vancouver
Baxter NT, Lesniak NA, Sinani H, Schloss PD, Koropatkin NM. The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome. mSphere. 2019. doi:10.1128/msphere.00528-18.
BibTeX
@article{nielson2019TheGlu,
title = {The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome},
author = {Nielson T. Baxter and Nicholas A. Lesniak and Hamide Sinani and Patrick D. Schloss and Nicole M. Koropatkin},
journal = {mSphere},
year = {2019},
doi = {10.1128/msphere.00528-18},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrients 2026
Open access · OA
Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives.
Genome Medicine 2016
Open access · CC-BY
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Nutrients 2020
Open access · CC-BY
The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome
Aging and Cancer 2024
Open access · CC-BY
The Gut Microbiome in Aging and Ovarian Cancer
The EMBO Journal 2009
Open access · OA
Telomeres and disease
Nutrients 2020
Open access · CC-BY